Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting

J Vasc Interv Radiol. 2008 Aug;19(8):1171-5. doi: 10.1016/j.jvir.2008.04.026. Epub 2008 Jun 17.

Abstract

Purpose: To assess the utility of maintaining and analyzing a quality-management database while investigating a subjectively perceived increase in the incidence of tunneled catheter and port dysfunction in a cohort of oncology outpatients.

Materials and methods: All 152 patients undergoing lytic therapy (2-4 mg alteplase) of a malfunctioning indwelling central venous catheter (CVC) from January through June 2004 at a single cancer center in the United States were included in a quality-management database. Patients were categorized by time to device failure and the initial method of catheter placement (surgery vs interventional radiology). Data were analyzed after 3 months, and areas of possible improvement were identified and acted upon. Three months of follow-up data were then collected and similarly analyzed.

Results: In a 6-month period, 152 patients treated for catheter malfunction received a total of 276 doses of lytic therapy. A 3-month interim analysis revealed a disproportionately high rate (34%) of early catheter malfunction (ECM; <30 days from placement). Postplacement radiographs demonstrated suboptimal catheter positioning in 67% of these patients, all of whom had surgical catheter placement. There was a 50% absolute decrease in the number of patients presenting with catheter malfunction in the period from April through June (P < .001). Evaluation of postplacement radiographs in these patients demonstrated a 50% decrease in the incidence of suboptimal positioning (P < .05).

Conclusions: Suboptimal positioning was likely responsible for some, but not all, cases of ECM. Maintenance of a quality-management database is a relatively simple intervention that can have a clear and important impact on the quality and cost of patient care.

Publication types

  • Clinical Trial

MeSH terms

  • Ambulatory Care / statistics & numerical data*
  • Antineoplastic Agents / administration & dosage*
  • Boston / epidemiology
  • Catheterization, Central Venous / statistics & numerical data*
  • Female
  • Humans
  • Incidence
  • Infusions, Intravenous / statistics & numerical data
  • Male
  • Neoplasms / drug therapy*
  • Neoplasms / epidemiology*
  • Prosthesis Failure
  • Quality Assurance, Health Care / statistics & numerical data*
  • Radiology, Interventional / statistics & numerical data*

Substances

  • Antineoplastic Agents